Related Experiment Video

Updated: Jun 22, 2026

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Effect of overweight/obesity on recovery after post-infectious glomerulonephritis

M N Lee1, U Shaikh, L Butani

  • 1Department of Pediatrics, and 2Section of Pediatric Nephrology, Department of Pediatrics, University of California Davis Medical Center, Sacramento, CA, USA.

Clinical Nephrology
|May 29, 2009
PubMed

Insights

Overweight children with post-infectious glomerulonephritis (PIGN) may experience prolonged kidney issues. While C3 levels normalized faster, other urinary abnormalities persisted longer in obese children, highlighting the need for close monitoring.

Area of Science:

  • Pediatric Nephrology
  • Renal Medicine
  • Glomerular Diseases

Background:

  • Post-infectious glomerulonephritis (PIGN) typically resolves quickly in children.
  • Overweight and obesity in children recovering from PIGN may be linked to persistent urinary abnormalities.

Purpose of the Study:

  • To investigate if overweight/obesity status prolongs the time to resolution of renal abnormalities following PIGN.

Main Methods:

  • Retrospective study of 20 children with PIGN.
  • Data abstracted included demographics, clinical, and laboratory findings.
  • Kaplan-Meier survival and log-rank tests analyzed the impact of overweight/obesity on outcomes.

Main Results:

  • 30% of children were overweight/obese; most presented with hypertension and proteinuria.
  • While GFR and blood pressure normalized quickly, proteinuria and microhematuria persisted in some.
  • Overweight/obese children showed trends toward longer resolution times for proteinuria, hypertension, and hematuria, but C3 normalization was faster.

Conclusions:

  • Overweight/obese children may exhibit increased residual renal injury post-PIGN.
  • Hemodynamic factors, not inflammatory ones, might explain the faster C3 normalization in obese children.
  • Close follow-up is recommended for overweight/obese children with PIGN to ensure optimal outcomes.
Abstract

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...